The company criticized for hiking the price of EpiPens by more than 400% in the past decade announced measures on Thursday to reduce the price for some individuals.
Mylan pharmaceuticals will offer a discount of up to $300 for patients whose health plans require “higher out-of-pocket costs.” This could cut the costs in half for some patients, according to a press release. The company will also expand access to a program that provides epipens to uninsured patients.
“We recognize the significant burden on patients from continued, rising insurance premiums,” said Mylan CEO Heather Bresch in the release. “Patients deserve increased price transparency and affordable care.”
Politicians on both sides of the aisle have criticized the rapid price increase for the medical devices in recent weeks, including Democratic presidential candidate Hillary Clinton.
More Must-Reads from TIME
- How Donald Trump Won
- The Best Inventions of 2024
- Why Sleep Is the Key to Living Longer
- Robert Zemeckis Just Wants to Move You
- How to Break 8 Toxic Communication Habits
- Nicola Coughlan Bet on Herself—And Won
- Why Vinegar Is So Good for You
- Meet TIME's Newest Class of Next Generation Leaders
Write to Justin Worland at justin.worland@time.com